◇◆

<notes> Notes

Section-like container element for one or more notes that are not part of the narrative flow (for example, note added in proof, dedication).

Usage/Remarks

Such notes are typically material outside the regular technical content of the document, extra material added by a contributor or by the publisher during or after the regular text has been processed, a note by the editor, or a note added after print publication.
There is no predefined list of types for the @notes-type attribute, but values publishers have used include “added-in-proof”, “dedication”, “conflict-of-interest”, “death-notice”, “editor-note”, “added-post-print”, “added-post-electronic-publication”, and “translator-note”.
A typical end-of-document note is a “Note in Proof”. A Note in Proof contains late-breaking news items or other material produced while the document was being typeset or was otherwise in production, that therefore happened too late to be included in the text of the work. This is typically NOT peer-reviewed content, and citations to other material within such content are usually integrated into the text or put inside the last paragraph, not listed separately in a bibliographic reference list <ref-list>.
The possibility of prepublication online as well as slightly differing content in the online versus print version of the same work has led to an increase in notes that are “only for the print” or “only for web” versions. The @specific-use attribute may be used to mark a note as belonging to only a specific format, such as “print-only”.
Related Elements
Not to be confused with the general notes and footnotes that can appear at the bottom of a table (<table-wrap>) and that should be tagged as ordinary paragraphs and footnotes inside a <table-wrap-foot> container element.
Attributes
notes-type
specific-use

Multi-lang Attributes

lang-focus
lang-focus-custom
lang-group
lang-source
lang-source-custom
lang-translate
lang-variant
lang-variant-custom

Base Attributes

id
xml:base
xml:lang
Models and Context
May be contained in
<abstract>, <ack>, <answer>, <app>, <back>, <bio>, <boxed-text>, <event>, <explanation>, <front>, <journal-meta>, <notes>, <option>, <question>, <sec>, <trans-abstract>
Description
The following, in order:
Content Model
<!ELEMENT  notes        %notes-model;                                >
Expanded Content Model

(sec-meta?, label?, title?, (address | alternatives | answer | answer-set | array | block-alternatives | boxed-text | chem-struct-wrap | code | explanation | fig | fig-group | graphic | media | preformat | question | question-wrap | question-wrap-group | supplementary-material | table-wrap | table-wrap-group | disp-formula | disp-formula-group | def-list | list | tex-math | mml:math | p | related-article | related-object | ack | disp-quote | speech | statement | verse-group | x)*, (sec)*, (notes | fn-group | glossary | ref-list)*)

Tagged Samples
Note added in proof 
...
<back>
 <glossary>...</glossary>
 <notes>
  <sec>
   <title>Note Added in Proof</title>
   <p>Similar sequence information has been obtained in another 
    study (S. Mishiro, personal communication) and has been 
    deposited under GenBank accession numbers &#x2013;. For 
    the purposes of HBV nomenclature, we have proposed that 
    the chimpanzee HBV be abbreviated as ChHBV.</p>
  </sec>
 </notes>
 <ref-list>...</ref-list>
 ...
</back>
...
Boilerplate 
...
<front>
 ...
 <article-meta>...</article-meta>
 <notes notes-type="disclaimer">
  <p><italic>The information and/or opinions expressed in this 
   Guest Editorial are those of the author(s). They are neither 
   endorsed nor disputed by <roman>Prescribing Physician</roman> 
   or the Pharma-Physician Coalition. Questions about or comments 
   on this editorial&rsquo;s content should be directed to the 
   corresponding author.</italic></p>
 </notes>
</front>
...
Dedication 
...
<front>
 ...
 <article-meta>...</article-meta>
 <notes notes-type="dedication">
  <p>We dedicate this paper to our professor, Dr. Robert 
   Jemmings, whose critique of the underlying study identified 
   potential bias in the analysis and strengthened our 
   argument.</p>
 </notes>
</front>
...
Editor’s notes 
...
<front>
 ...
 <article-meta>...</article-meta>
 <notes notes-type="editor-note">
  <p><sc>EDITOR&rsquo;S NOTE:</sc>  The study examined in 
   this article was neither blinded nor placebo-controlled.  
   More recent studies suggest that traditional medications 
   when compared with placebos do decrease symptoms of this 
   condition. Further research is needed to ascertain the 
   efficacy of such medications; until research is conducted, 
   traditional medications may be an effectual treatment.</p>
 </notes>
</front>
...
Post publication information 
...
<front>
 ...
 <article-meta>...</article-meta>
 <notes notes-type="after-epub">
  <p>After publication, the authors discovered an error in 
   the text concerning the administration of the medication 
   levothyroxine.  The text reads:  &ldquo;Individuals 
   prescribed the thyroid hormone, levothyroxine, should 
   eat within thirty minutes of taking the medication.&rdquo;  
   The text should read: &ldquo;Individuals prescribed the 
   thyroid hormone, levothyroxine, should <italic>not</italic> 
   eat within thirty minutes of taking the medication.&rdquo;</p>
 </notes>
</front>
...
Conflict of interest information 
...
<front>
 ...
 <article-meta>...</article-meta>
 <notes notes-type="conflict-interest">
  <p><bold>Competing interests:</bold> RM reports that 
   he is employed by an academic medical center that has 
   both intellectual property and performs clinical trials. 
   DK declares that he has no competing interests.</p>
 </notes>
</front>
...
Related Resources